Skip to main content

Table 1 Clinical and pathological characteristics

From: Nodal skip metastasis in thoracic esophageal squamous cell carcinoma: a cohort study

Number

88

Age (years)a

62 (57–70)

Sex Male: Female

71:17

Advanced liver disease

18 (20.5)

Pulmonary disease

17 (19.3)

Tumor location:

 Upper thoracic esophagus

14 (15.9)

 Middle thoracic esophagus

38 (43.2)

 Lower thoracic esophagus

36 (40.9)

Tumor differentiation:

 Well

16 (18.2)

 Moderately

57 (64.8)

 Poor

15 (17.0)

Tumor length (mm)a

50 (40–70)

Pathologic T stage

 T1

11 (12.5)

 T2

10 (11.4)

 T3

58 (65.9)

 T4

9 (10.2)

Harvested lymph nodesa

17 (12–25)

Lymph node metastasis:

 Peritumoral or Peritumoral and distant (non-NSM)

72 (81.8)

 Only distant (NSM)

16 (18.2)

Adjuvant therapy: yes

28 (31.8)

  1. Data expressed as n (%) or amedian(IQR). NSM: nodal skip metastasis